The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Methotrexate

abstract

  • Initial treatment with subcutaneous MTX was associated with lower rates of treatment changes, no difference in toxicity and some improvements in disease control versus oral MTX over the first year in patients with ERA.

publication date

  • June 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1136/annrheumdis-2014-206504

PubMed ID

  • 25979945

Additional Document Info

start page

  • 1003

end page

  • 8

volume

  • 75

number

  • 6